CAS: 123367-26-0; (E)-3-(Dimethylamino)-1-(Pyridin-3-yl)Prop-2-En-1-One

该化合物是一个α,β-不饱和克酮,具有丙烯和二甲基氨基替代成分,使其成为有机合成的多用途中间体,其同质系统可增强迈克尔添加和循环反应的回活动,而富电子的二甲基氨基组可促进核生殖性改变. 海藻为金属催化工艺提供了协调潜力. 这种化合物在制药和农用化学研究中特别有用,因为它具有结构灵活性和能力,能够作为环球框架的前体. 在标准条件下,高纯度和稳定性确保了合成应用的可靠性能. 其定义明确的分子结构允许在复杂的分子组装中精确地实现功能化.

结构式图片

相似化合物

55314-16-4 123367-27-1 75415-01-9

欧盟法规

C&L通报

上下游产品

methyl-3-pyridylketone N,N-dimethyl-formamide dimethyl acetalN,N-dimethyl-formamide dimethyl acetal formic acid ethyl ester N,N-dimethylformamide diethyl diacetal N-(5-nitro-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidineamine imatinib 4-pyridin-3-ylpyrimidin-2-ylamine 6-methyl-1-N-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine

合成工艺路线路线简述

    3-乙酰基吡啶 以74%的收率获得
    参考文献:Bennett G. B.; Mason R. B.; Alden L. J.; Roach J. B.,J. Med. Chem.,1978,21,No 7,623-628
    标题:Bennett G. B.; Mason R. B.; Alden L. J.; Roach J. B.,J. Med. Chem.,1978,21,No 7,623-628

    海关参考信息

    专利信息


    专利号:US-8334381-B2
    优先权日:2006-11-16
    标题 :Process for the preparation of intermediates useful in the synthesis of imatinib
    发明人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO
    权利人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO; ITALIANA SINT SPA
    摘要:It is the object of the present invention a process for the preparation of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and analogues thereof, intermediates useful for the synthesis of Imatinib, or 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide.

    专利号:US-5064963-A
    优先权日:1990-04-25
    标 题 :Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines
    发明人:DEAN WILLIAM D
    权利人:AMERICAN CYANAMID CO
    摘要:The invention provides a novel process for producing N-[3-(1H-imidazol-1-yl)phenyl]-4-(substituted)-2 pyrimidinamine compounds in which the substituent is a 2-pyridinyl, 3-pyrindinyl, 4-pyridinyl, 2-furanyl or 2-thienyl group. The process includes the steps of (1) reacting a 3-(1H-imidazol-1-yl)benzamine with cyanamide and a halogen acid while controlling the pH of the reaction between pH about 2 to abourt 3.5 and recovering a [3-(1H-imidazol-1-yl)phenyl] guanidine dihydrohalide and (2) reacting the [3-(1H-imidazol-1-yl)phenyl] guanidine dihydrohalide so recovered with an appropriately substituted 3-dimethylamino-1-(substituted)-2-propen-1-one and a base at a pH of from about 10.5 to about 11.5 and recovering the N-[3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidamine compound so produced. The novel process provides improved yield and purity by adhering to the stated crucial pH ranges.

    专利号:US-2023065387-A1
    优先权日:2019-10-14
    标题:Synthesis of tyrosine kinase inhibitors

    专利号:US-2011097268-A1
    优先权日:2006-08-23
    标 题 :Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers
    发明人:BORNMANN WILLIAM; ALAUDDIN MIAN; GELOVANI JURI; GHOSH PRADIP; GUO LIWEI; HAN DONGMEI; MAXWELL DAVID; MUKHOPADHYAY UDAY; PENG ZHENGHONG; SHAVRIN ALEKSANDR; YING YUNMING
    权利人:UNIV TEXAS
    摘要:We disclose methods of synthesizing radiohalidated organic compounds and their use in positron emission tomography (PET) imaging of cancer cells.

    专利号:US-10738028-B2
    优先权日:2016-05-11
    标题:Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor
    发明人:HU WENHAO; LV FENGPING; TANG YANG; LI ZIYAN; CHEN CHEN; WEI JIANHAI; DONG SUZHEN; QIAN YU
    权利人:RUDONG RUIEN PHARMACEUTICAL TECH CO LTD
    摘要:Disclosed are the anti-bacterial activity and the anti-tumor activity of a class of new spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, are effective against many antibiotic-resistant Gram-positive strains by inhibiting the activity of the peptide deformylase required in the synthesis of bacterial proteins, and do not affect the synthetic process of the main proteins of the human body, thus selectively killing bacteria. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, can affect the energy balance of the cancer cells through inhibiting the peptide deformylase of the mitochondria in the cells, so that the mitochondrial membrane is depolarized, ATP is exhausted and cell apoptosis is promoted, and has good inhibitory activities on many cancer cell strains such as colorectal cancer, leukemia, lung cancer, gastric cancer, cervical cancer, breast cancer, prostatic cancer, liver cancer and osteosarcoma at relatively lower concentrations. The structure of exemplary invention spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitors are represented by one or more of:

    专利号:WO-2012022217-A1
    优先权日:2010-08-20
    标 题 :N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide derivatives, a preparation method and use for synthesis of imatinib thereof
    科邦特化工(杭州)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.capot.cn
    企业联系电话:0571-85586718👤
    📞科邦特化工(杭州)有限公司 ⚠️参考联系方式
    联系人:景先生
    电话:0571-85586718
    手机:13336094967(外贸专线);13336195806(内需专线)
    传真:0571-85864795
    邮箱:sales@capot.com
    通信地址: 浙江省杭州市滨江区江陵路88号万轮科技园
    邮编: 310051
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市滨江区江陵路88号万轮科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Grimmer, J.; Krieg, S.-C.; Manolikakes, G., Science of Synthesis Knowledge Updates, (2021) 1, 237.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知